Literature DB >> 33678562

Management of juvenile idiopathic arthritis: Preliminary qualitative findings from the National Dental Practice-Based Research Network.

Chung How Kau1, Veerasathpurush Allareddy2, Peter Stoustrup3, Thomas Pedersen4, Brian Kinard5, Randy Q Cron6, Matthew L Stoll6, Gregg H Gilbert7.   

Abstract

INTRODUCTION: Juvenile idiopathic arthritis (JIA) is the most common chronic arthritis in childhood and represents a series of chronic inflammatory arthritides that develop before 16 years of age.
METHODS: In 2020, investigators with an interest in the management of JIA engaged the National Dental Practice-Based Research Network by conducting a preliminary qualitative questionnaire ("Quick Poll") that comprised 6 questions about JIA management.
RESULTS: A total of 604 persons responded. Results suggested that there was an interest in the management of JIA, but many clinicians did not feel that they had the necessary knowledge or experience to treat these patients.
CONCLUSIONS: The study clearly highlights a distinct gap in awareness and understanding of JIA among clinicians polled. Future work in this area should focus on education and awareness across multiple specialties, clinical guidelines for the management of JIA, and a data repository of long-term outcomes.
Copyright © 2021 World Federation of Orthodontists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical orthodontics; Juvenile idiopathic arthritis; Practice based network

Year:  2021        PMID: 33678562     DOI: 10.1016/j.ejwf.2021.01.003

Source DB:  PubMed          Journal:  J World Fed Orthod        ISSN: 2212-4438


  2 in total

Review 1.  Research progress in drug therapy of juvenile idiopathic arthritis.

Authors:  Wen-Jia Zhao; Jiang-Hong Deng; Cai-Feng Li
Journal:  World J Pediatr       Date:  2022-04-01       Impact factor: 2.764

2.  An Evaluation of Jaw Tracking Movements in Patients with Total Joint Replacements versus a Control Group.

Authors:  Farhana Rahman; Felice Femiano; Patrick J Louis; Chung How Kau
Journal:  Medicina (Kaunas)       Date:  2022-05-30       Impact factor: 2.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.